Timothy Rolph Akero Therapeutics, Inc. (AKRO) insider trading activity
Timothy Rolph is Chief Scientific Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 167,124 shares of AKRO, which is worth approximately $8.61 Million. The most recent transaction as insider was on Oct 06, 2022, when has been sold 22,500 shares (Common Stock) at a price of $39.29 per share, resulting in proceeds of $884,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
167K
1.53%
3M change
7.79%
12M change
Total Value Held
$8.61 Million
Timothy Rolph Transaction History
TR
Timothy Rolph
Chief Scientific Officer
South San Francisco, CA